Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
David Roth Insider Profile
4 Followers
David Roth, CMO at Infinity Pharmaceuticals, holds 0.00 shares in Syros Pharmaceuticals (Ticker: SYRS), holds 79.00 shares in Infinity Pharmaceuticals (Ticker: INFIQ). Most recently, David Roth Sold ― shares of Syros Pharmaceuticals on Nov 20, 2024 for an estimated value of 2.30K.
David Roth has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that David Roth holds in companies
Most Profitable Insider Trade
The most profitable trade made by David Roth
David Roth's Trading History
Infinity Pharmaceuticals
Feb 07, 2014
CMO
Uninformative Buy
―
$1.26
Syros Pharmaceuticals
Nov 20, 2024
CMO
Informative Sell
2.30K
$0.00
List of latest transactions for each holding click on a transaction to see David Roth's performance on stock
You May Also Like
David Roth insider profile FAQ
What is the percentage of profitable transactions made by David Roth?
The percentage of profitable transactions made by David Roth is ―.
What is the average return per transaction made by David Roth?
The average return per transaction made by David Roth is ―.
What stocks does David Roth hold?
David Roth holds: INFIQ, SYRS stocks.
What was David Roth’s latest transaction?
David Roth latest transaction was an Informative Sell of $2.30K.
What was David Roth's most profitable transaction?
David Roth’s most profitable transaction was an Informative Sell of SYRS stock on November 20, 2024. The return on the trade was 31.00%.
What is David Roth's role in Infinity Pharmaceuticals?
David Roth's role in Infinity Pharmaceuticals is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.